Today, we talk about some RSV competition that’s brewing, how Alnylam’s CEO spoke about its plans with ATTR-CM, and more. Alnylam Pharmaceuticals is expanding the footprint of its RNA-based ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

Testing was performed using BinaxNOW RSV immunochromatographic assays to detect RSV fusion protein antigen in nasopharyngeal swabs (93% sensitivity, 93% specificity, Alere Scarborough Inc ...

Enanta Pharmaceuticals has linked its respiratory syncytial virus (RSV) antiviral to significant reductions in viral load and symptoms in a phase 2a challenge study. The biotech said the results ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren't as worried about it anymore. RSV is common but can be dangerous ...

Dr. Nina Shapiro is a physician writer who dispels health myths. While clinical trials are currently underway to provide RSV vaccines to pregnant women in order to protect their soon-to-be ...

Cold and flu season — otherwise known as mid-October — is upon us. But this year, several advancements in vaccines could help families keep viruses at bay. One of the new developments is a ...

BUT HOW DO YOU KNOW IF IT’S THE FLU, RSV OR COVID? TO HELP YOU UNDERSTAND THE DIFFERENCE, THIS MORNING WE WELCOME DOCTOR VANESSA WALKER WITH SUTTER HEALTH. THANK YOU SO MUCH FOR BEING HERE.

Rates of SUID per 100,000 live births rose by 10% from 2019 to 2021. A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of respiratory syncytial virus ...